Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 15, 1999

View Archived Issues

GPC, Novalon Enter Alliance To Discover Novel Antibiotics

Gene Inactivation, Not Mutation May Be Cause Of Some Cancers

Micrologix Working On Phase III; Antimicrobial Drug On Fast Track

Gemini, Celera Collaborate In Area Of Age-Related Diseases

IGT Subsidiary To Spin Out After Investment From BIRC

BioIndustry Calls For National Center After Visit To The U.S.

CAT Signs Deal With AstraZeneca, Sees Positive Results In Trial

D-Pharm Taking Epilepsy Drug Into Phase II After First Studies

Evotec Going Public In Germany To Advance Discovery Platforms

Peptide, SmithKline Continue Work Despite Recent Setback

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.